Loading…

Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures

The treatment of infections caused by bacteria resistant to the vast majority of antibiotics is a challenge worldwide. To evaluate the effect of S-thanatin (an analog of thanatin, a cationic antimicrobial peptide isolated from the hemipteran insect Podisus maculiventris) against microbial resistant...

Full description

Saved in:
Bibliographic Details
Published in:Current microbiology 2009-08, Vol.59 (2), p.147-153
Main Authors: Wu, Guo-Qiu, Ding, Jia-Xuan, Li, Lin-Xian, Wang, Hai-liang, Zhao, Rui, Shen, Zi-Long
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963
cites cdi_FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963
container_end_page 153
container_issue 2
container_start_page 147
container_title Current microbiology
container_volume 59
creator Wu, Guo-Qiu
Ding, Jia-Xuan
Li, Lin-Xian
Wang, Hai-liang
Zhao, Rui
Shen, Zi-Long
description The treatment of infections caused by bacteria resistant to the vast majority of antibiotics is a challenge worldwide. To evaluate the effect of S-thanatin (an analog of thanatin, a cationic antimicrobial peptide isolated from the hemipteran insect Podisus maculiventris) against microbial resistant to antibiotics, we studied its bactericidal kinetics, synergistic effect, resistance, and activity on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures. The bactericidal rate of S-thanatin was more than 99% against K. pneumoniae ATCC 700603 when bacterial cultures were monitored for 60 min. The peptide was synergistic with β-lactam cefepime in most of the clinical MDR isolates tested (7/8). An average value of FIC was 0.3708. No synergy was found between the peptide and amoxicillin, gentamycin, tetracycline, or ciprofloxacin in all bacteria tested. A total of 48 isolates of K. pneumoniae with different resistance spectrum tested was susceptible to S-thanatin. The MICs were 6.25-25 μg/ml. No significant difference in the MICs of S-thanatin between the sensitive isolates and the resistant isolates to single antibiotic was observed (P > 0.05). The resistance of K. pneumoniae ATCC 700603 to S-thanatin was slightly higher, when cultured at sub-inhibitory concentration for 5 days. S-thanatin may be an attractive candidate for developing into an antimicrobial agent.
doi_str_mv 10.1007/s00284-009-9410-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_856762113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1893241051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963</originalsourceid><addsrcrecordid>eNp9ks1uEzEUhUcIREPhAdiAxYbVwPXPTMbLKOWnohKItGvLnrlOXE3sYHuK-lo8IQ4TVIkFK0u-3zlH18dV9ZLCOwqwfJ8AWCdqAFlLQaFmj6oFFZzVICV9XC2AC153bUPPqmcp3QJQJoE-rc6oFI0sDovq16rP7s7lexIsyTskK5_d3vUxGKdH8g0P2Q1ItB_I9U57nZ0viB7Dlmzq_PcmeLIenXd9kVymMOqM6Wj4ZUSTHI6jJgeP0z54p5F8x-RS1j6THMg6-DssmaGY_gk3LmTXJ_LT5R25cNZiLHOyyXHq8xQxPa-eWD0mfHE6z6ubjx-u15_rq6-fLterq7oXrMm1AMmsATmYTi5RM2EplxKEMcCoaXjX2AYBl4zhIDo7iBY6YQ0ObDC8ly0_r97OvocYfkyYstq71B-X8RimpLqmXbaMUl7IN_-Qt2GKZaGkGDSMAZe0QHSGytumFNGqQ3R7He8VBXWsU811qlKnOtapWNG8OhlPZo_Dg-LUXwHYDKQy8luMD8n_c309i6wOSm-jS-pmw4ByoOWvUNnw3yZmtvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205220391</pqid></control><display><type>article</type><title>Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures</title><source>Springer Nature</source><creator>Wu, Guo-Qiu ; Ding, Jia-Xuan ; Li, Lin-Xian ; Wang, Hai-liang ; Zhao, Rui ; Shen, Zi-Long</creator><creatorcontrib>Wu, Guo-Qiu ; Ding, Jia-Xuan ; Li, Lin-Xian ; Wang, Hai-liang ; Zhao, Rui ; Shen, Zi-Long</creatorcontrib><description>The treatment of infections caused by bacteria resistant to the vast majority of antibiotics is a challenge worldwide. To evaluate the effect of S-thanatin (an analog of thanatin, a cationic antimicrobial peptide isolated from the hemipteran insect Podisus maculiventris) against microbial resistant to antibiotics, we studied its bactericidal kinetics, synergistic effect, resistance, and activity on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures. The bactericidal rate of S-thanatin was more than 99% against K. pneumoniae ATCC 700603 when bacterial cultures were monitored for 60 min. The peptide was synergistic with β-lactam cefepime in most of the clinical MDR isolates tested (7/8). An average value of FIC was 0.3708. No synergy was found between the peptide and amoxicillin, gentamycin, tetracycline, or ciprofloxacin in all bacteria tested. A total of 48 isolates of K. pneumoniae with different resistance spectrum tested was susceptible to S-thanatin. The MICs were 6.25-25 μg/ml. No significant difference in the MICs of S-thanatin between the sensitive isolates and the resistant isolates to single antibiotic was observed (P &gt; 0.05). The resistance of K. pneumoniae ATCC 700603 to S-thanatin was slightly higher, when cultured at sub-inhibitory concentration for 5 days. S-thanatin may be an attractive candidate for developing into an antimicrobial agent.</description><identifier>ISSN: 0343-8651</identifier><identifier>EISSN: 1432-0991</identifier><identifier>DOI: 10.1007/s00284-009-9410-2</identifier><identifier>PMID: 19459007</identifier><language>eng</language><publisher>New York: New York : Springer-Verlag</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Antimicrobial agents ; Antimicrobial Cationic Peptides - isolation &amp; purification ; Antimicrobial Cationic Peptides - pharmacology ; Biomedical and Life Sciences ; Biotechnology ; Drug resistance ; Drug Resistance, Bacterial ; Drug Synergism ; Heteroptera - chemistry ; Klebsiella Infections - microbiology ; Klebsiella pneumoniae ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - isolation &amp; purification ; Life Sciences ; Microbial Sensitivity Tests ; Microbial Viability - drug effects ; Microbiology ; Peptides ; Peptides, Cyclic - isolation &amp; purification ; Peptides, Cyclic - pharmacology ; Podisus maculiventris ; Synergistic effect</subject><ispartof>Current microbiology, 2009-08, Vol.59 (2), p.147-153</ispartof><rights>Springer Science+Business Media, LLC 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963</citedby><cites>FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19459007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Guo-Qiu</creatorcontrib><creatorcontrib>Ding, Jia-Xuan</creatorcontrib><creatorcontrib>Li, Lin-Xian</creatorcontrib><creatorcontrib>Wang, Hai-liang</creatorcontrib><creatorcontrib>Zhao, Rui</creatorcontrib><creatorcontrib>Shen, Zi-Long</creatorcontrib><title>Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures</title><title>Current microbiology</title><addtitle>Curr Microbiol</addtitle><addtitle>Curr Microbiol</addtitle><description>The treatment of infections caused by bacteria resistant to the vast majority of antibiotics is a challenge worldwide. To evaluate the effect of S-thanatin (an analog of thanatin, a cationic antimicrobial peptide isolated from the hemipteran insect Podisus maculiventris) against microbial resistant to antibiotics, we studied its bactericidal kinetics, synergistic effect, resistance, and activity on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures. The bactericidal rate of S-thanatin was more than 99% against K. pneumoniae ATCC 700603 when bacterial cultures were monitored for 60 min. The peptide was synergistic with β-lactam cefepime in most of the clinical MDR isolates tested (7/8). An average value of FIC was 0.3708. No synergy was found between the peptide and amoxicillin, gentamycin, tetracycline, or ciprofloxacin in all bacteria tested. A total of 48 isolates of K. pneumoniae with different resistance spectrum tested was susceptible to S-thanatin. The MICs were 6.25-25 μg/ml. No significant difference in the MICs of S-thanatin between the sensitive isolates and the resistant isolates to single antibiotic was observed (P &gt; 0.05). The resistance of K. pneumoniae ATCC 700603 to S-thanatin was slightly higher, when cultured at sub-inhibitory concentration for 5 days. S-thanatin may be an attractive candidate for developing into an antimicrobial agent.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial Cationic Peptides - isolation &amp; purification</subject><subject>Antimicrobial Cationic Peptides - pharmacology</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug Synergism</subject><subject>Heteroptera - chemistry</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - isolation &amp; purification</subject><subject>Life Sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbial Viability - drug effects</subject><subject>Microbiology</subject><subject>Peptides</subject><subject>Peptides, Cyclic - isolation &amp; purification</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Podisus maculiventris</subject><subject>Synergistic effect</subject><issn>0343-8651</issn><issn>1432-0991</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9ks1uEzEUhUcIREPhAdiAxYbVwPXPTMbLKOWnohKItGvLnrlOXE3sYHuK-lo8IQ4TVIkFK0u-3zlH18dV9ZLCOwqwfJ8AWCdqAFlLQaFmj6oFFZzVICV9XC2AC153bUPPqmcp3QJQJoE-rc6oFI0sDovq16rP7s7lexIsyTskK5_d3vUxGKdH8g0P2Q1ItB_I9U57nZ0viB7Dlmzq_PcmeLIenXd9kVymMOqM6Wj4ZUSTHI6jJgeP0z54p5F8x-RS1j6THMg6-DssmaGY_gk3LmTXJ_LT5R25cNZiLHOyyXHq8xQxPa-eWD0mfHE6z6ubjx-u15_rq6-fLterq7oXrMm1AMmsATmYTi5RM2EplxKEMcCoaXjX2AYBl4zhIDo7iBY6YQ0ObDC8ly0_r97OvocYfkyYstq71B-X8RimpLqmXbaMUl7IN_-Qt2GKZaGkGDSMAZe0QHSGytumFNGqQ3R7He8VBXWsU811qlKnOtapWNG8OhlPZo_Dg-LUXwHYDKQy8luMD8n_c309i6wOSm-jS-pmw4ByoOWvUNnw3yZmtvc</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Wu, Guo-Qiu</creator><creator>Ding, Jia-Xuan</creator><creator>Li, Lin-Xian</creator><creator>Wang, Hai-liang</creator><creator>Zhao, Rui</creator><creator>Shen, Zi-Long</creator><general>New York : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7SS</scope></search><sort><creationdate>20090801</creationdate><title>Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures</title><author>Wu, Guo-Qiu ; Ding, Jia-Xuan ; Li, Lin-Xian ; Wang, Hai-liang ; Zhao, Rui ; Shen, Zi-Long</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial Cationic Peptides - isolation &amp; purification</topic><topic>Antimicrobial Cationic Peptides - pharmacology</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug Synergism</topic><topic>Heteroptera - chemistry</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - isolation &amp; purification</topic><topic>Life Sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbial Viability - drug effects</topic><topic>Microbiology</topic><topic>Peptides</topic><topic>Peptides, Cyclic - isolation &amp; purification</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Podisus maculiventris</topic><topic>Synergistic effect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Guo-Qiu</creatorcontrib><creatorcontrib>Ding, Jia-Xuan</creatorcontrib><creatorcontrib>Li, Lin-Xian</creatorcontrib><creatorcontrib>Wang, Hai-liang</creatorcontrib><creatorcontrib>Zhao, Rui</creatorcontrib><creatorcontrib>Shen, Zi-Long</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><jtitle>Current microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Guo-Qiu</au><au>Ding, Jia-Xuan</au><au>Li, Lin-Xian</au><au>Wang, Hai-liang</au><au>Zhao, Rui</au><au>Shen, Zi-Long</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures</atitle><jtitle>Current microbiology</jtitle><stitle>Curr Microbiol</stitle><addtitle>Curr Microbiol</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>59</volume><issue>2</issue><spage>147</spage><epage>153</epage><pages>147-153</pages><issn>0343-8651</issn><eissn>1432-0991</eissn><abstract>The treatment of infections caused by bacteria resistant to the vast majority of antibiotics is a challenge worldwide. To evaluate the effect of S-thanatin (an analog of thanatin, a cationic antimicrobial peptide isolated from the hemipteran insect Podisus maculiventris) against microbial resistant to antibiotics, we studied its bactericidal kinetics, synergistic effect, resistance, and activity on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures. The bactericidal rate of S-thanatin was more than 99% against K. pneumoniae ATCC 700603 when bacterial cultures were monitored for 60 min. The peptide was synergistic with β-lactam cefepime in most of the clinical MDR isolates tested (7/8). An average value of FIC was 0.3708. No synergy was found between the peptide and amoxicillin, gentamycin, tetracycline, or ciprofloxacin in all bacteria tested. A total of 48 isolates of K. pneumoniae with different resistance spectrum tested was susceptible to S-thanatin. The MICs were 6.25-25 μg/ml. No significant difference in the MICs of S-thanatin between the sensitive isolates and the resistant isolates to single antibiotic was observed (P &gt; 0.05). The resistance of K. pneumoniae ATCC 700603 to S-thanatin was slightly higher, when cultured at sub-inhibitory concentration for 5 days. S-thanatin may be an attractive candidate for developing into an antimicrobial agent.</abstract><cop>New York</cop><pub>New York : Springer-Verlag</pub><pmid>19459007</pmid><doi>10.1007/s00284-009-9410-2</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0343-8651
ispartof Current microbiology, 2009-08, Vol.59 (2), p.147-153
issn 0343-8651
1432-0991
language eng
recordid cdi_proquest_miscellaneous_856762113
source Springer Nature
subjects Animals
Anti-Bacterial Agents - pharmacology
Antibiotics
Antimicrobial agents
Antimicrobial Cationic Peptides - isolation & purification
Antimicrobial Cationic Peptides - pharmacology
Biomedical and Life Sciences
Biotechnology
Drug resistance
Drug Resistance, Bacterial
Drug Synergism
Heteroptera - chemistry
Klebsiella Infections - microbiology
Klebsiella pneumoniae
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - isolation & purification
Life Sciences
Microbial Sensitivity Tests
Microbial Viability - drug effects
Microbiology
Peptides
Peptides, Cyclic - isolation & purification
Peptides, Cyclic - pharmacology
Podisus maculiventris
Synergistic effect
title Activity of the Antimicrobial Peptide and Thanatin Analog S-thanatin on Clinical Isolates of Klebsiella pneumoniae Resistant to Conventional Antibiotics with Different Structures
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T02%3A47%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activity%20of%20the%20Antimicrobial%20Peptide%20and%20Thanatin%20Analog%20S-thanatin%20on%20Clinical%20Isolates%20of%20Klebsiella%20pneumoniae%20Resistant%20to%20Conventional%20Antibiotics%20with%20Different%20Structures&rft.jtitle=Current%20microbiology&rft.au=Wu,%20Guo-Qiu&rft.date=2009-08-01&rft.volume=59&rft.issue=2&rft.spage=147&rft.epage=153&rft.pages=147-153&rft.issn=0343-8651&rft.eissn=1432-0991&rft_id=info:doi/10.1007/s00284-009-9410-2&rft_dat=%3Cproquest_cross%3E1893241051%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c425t-4092fb09db897ea24f139904bb021b5385f5e0e722ed48fd46084fbed2db3c963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205220391&rft_id=info:pmid/19459007&rfr_iscdi=true